Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).

Examples of FDA-regulated studies

• Clinical trials for FDA-regulated products (e.g., drugs, biologics, devices).
• Post-market surveillance of FDA-approved products.
• Investigational New Drug (IND) or Investigational Device Exemption (IDE) studies.
• Studies to support FDA submissions (e.g., marketing applications like NDAs, BLAs, PMAs).